Works by Keren, Shoshana

Results: 8

Recombinant Human Erythropoietin in the Treatment of Cancer-Related Anaemia.

Published in:

Oncology, 1994, v. 51, n. 6, p. 497, doi. 10.1159/000227392

By:

Falkson, Carla I.;
Keren-Rosenberg, Shoshana;
Uys, A.;
Falkson, Geoffrey;
Stevens, K.;
Vermaak, W.J.H.

Publication type:

Article

Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study.

Published in:

Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdab188

By:

Peled, Nir;
Kian, Waleed;
Inbar, Edna;
Goldstein, Iris M.;
Zemel, Melanie;
Rotem, Ofer;
Rozenblum, Anna B.;
Nechushtan, Hovav;
Dudnik, Elizabeth;
Levin, Daniel;
Zer, Alona;
Keren-Rosenberg, Shoshana;
Yust-Katz, Shlomit;
Fuchs, Vered;
Remilah, Areen A.;
Shelef, Ilan;
Roisman, Laila C.

Publication type:

Article

A Single-Center Experience in Combined Oncological–Surgical Treatment for Resectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC).

Published in:

Diseases, 2024, v. 12, n. 5, p. 98, doi. 10.3390/diseases12050098

By:

Faber, Dan Levy;
Agbarya, Abed;
Caspy, Ben;
Lapidot, Moshe;
Rosenberg, Shoshana Keren;
Schneer, Sonia;
Sharoni, Erez;
Galili, Ronen

Publication type:

Article

dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50%.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 122, doi. 10.1016/j.cllc.2021.12.006

By:

Holtzman, Liran;
Moskovitz, Mor;
Urban, Damien;
Nechushtan, Hovav;
Keren, Shoshana;
Reinhorn, Daniel;
Wollner, Mira;
Daher, Sameh;
Rottenberg, Yakir;
Rovitzky, Yulia;
Shochat, Tzippy;
Bar, Jair;
Dudnik, Elizabeth

Publication type:

Article

Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort.

Published in:

2019

By:

Dudnik, Elizabeth;
Bar, Jair;
Peled, Nir;
Bshara, Elias;
Kuznetsov, Teodor;
Cohen, Aharon Yonathan;
Shochat, Tzippy;
Nechushtan, Hovav;
Onn, Amir;
Agbarya, Abed;
Moskovitz, Mor;
Keren, Shoshana;
Popovits-Hadar, Noa;
Urban, Damien;
Mishaeli, Moshe;
Rabinovich, Natalie Maimon;
Brenner, Ronen;
Zer, Alona;
Rotem, Ofer;
Roisman, Laila C.

Publication type:

journal article

ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data.

Published in:

Oncologist, 2022, v. 27, n. 1, p. e76, doi. 10.1093/oncolo/oyab005

By:

Moskovitz, Mor;
Dudnik, Elizabeth;
Shamai, Sivan;
Rotenberg, Yakir;
Popovich-Hadari, Noa;
Wollner, Mira;
Zer, Alona;
Gottfried, Maya;
Mishaeli, Moshe;
Rosenberg, Shoshana Keren;
Onn, Amir;
Merimsky, Ofer;
Urban, Damien;
Peled, Nir;
Maimon, Natalie;
Bar, Jair

Publication type:

Article

Linkage between Psychological Factors and Response to Immune Checkpoint Inhibitor Therapy: A Preliminary Study.

Published in:

Cells (2073-4409), 2023, v. 12, n. 20, p. 2471, doi. 10.3390/cells12202471

By:

Cohen, Miri;
Shamay, Yosi;
Czamanski-Cohen, Johanna;
Shulman, Katerina;
Keren Rosenberg, Shoshana;
Abu-Amna, Mahmoud;
Turgeman, Ilit;
Merkin Livshits, Ludmila;
Birenboim, Revital;
Dines, Monica;
Bar-Sela, Gil

Publication type:

Article

Statins, aspirin and risk of venous thromboembolic events in breast cancer patients.

Published in:

Journal of Thrombosis & Thrombolysis, 2014, v. 38, n. 1, p. 32, doi. 10.1007/s11239-013-1015-8

By:

Shai, Ayelet;
Rennert, Hedy;
Lavie, Ofer;
Ballan-Haj, Muona;
Bitterman, Arie;
Steiner, Mariana;
Keren, Shoshana;
Rennert, Gad

Publication type:

Article